Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.

Saved in:
Bibliographic Details
Title: Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.
Authors: Dörr J; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Gregor L; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Lacher SB; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.; Servier Deutschland, Munich, Germany., Oner A; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Sun Y; Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Piseddu I; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine II, LMU University Hospital, Munich, Germany.; Gene Center, Department of Biochemistry, LMU Munich, Munich, Germany., Fertig L; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Spajic S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Lesch S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Michaelides S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Seifert M; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Gottschlich A; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine III, LMU University Hospital, LMU, Munich, Germany., Samson N; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Majed L; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Briukhovetska D; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Simnica D; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Hartmann V; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Gabriel K; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Cohen S; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Boland GM; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Andreu-Sanz D; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Carlini E; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Stock S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine III, LMU University Hospital, LMU, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany., Holtermann A; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany., Müller PJ; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Strzalkowski T; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Trefny MP; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany., Endres S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, Munich, Germany., Jenkins RW; Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Böttcher JP; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.; M3 Research Center, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.; Department of Experimental Immunology, Institute of Immunology, University of Tübingen, Tübingen, Germany., Kobold S; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Center for Lung Research (DZL), Partner Site Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.
Source: Nature biomedical engineering [Nat Biomed Eng] 2026 Apr; Vol. 10 (4), pp. 697-710. Date of Electronic Publication: 2026 Feb 11.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101696896 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2157-846X (Electronic) Linking ISSN: 2157846X NLM ISO Abbreviation: Nat Biomed Eng Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41673138
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ablation of prostaglandin E<subscript>2</subscript> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dörr+J%22">Dörr J</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gregor+L%22">Gregor L</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Lacher+SB%22">Lacher SB</searchLink>; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.; Servier Deutschland, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Oner+A%22">Oner A</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Sun+Y%22">Sun Y</searchLink>; Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Piseddu+I%22">Piseddu I</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine II, LMU University Hospital, Munich, Germany.; Gene Center, Department of Biochemistry, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Fertig+L%22">Fertig L</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Spajic+S%22">Spajic S</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Lesch+S%22">Lesch S</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Michaelides+S%22">Michaelides S</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Seifert+M%22">Seifert M</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gottschlich+A%22">Gottschlich A</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine III, LMU University Hospital, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Samson+N%22">Samson N</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Majed+L%22">Majed L</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Briukhovetska+D%22">Briukhovetska D</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Simnica+D%22">Simnica D</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Hartmann+V%22">Hartmann V</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gabriel+K%22">Gabriel K</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Cohen+S%22">Cohen S</searchLink>; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Boland+GM%22">Boland GM</searchLink>; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Andreu-Sanz+D%22">Andreu-Sanz D</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Carlini+E%22">Carlini E</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Stock+S%22">Stock S</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; Department of Medicine III, LMU University Hospital, LMU, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Holtermann+A%22">Holtermann A</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Müller+PJ%22">Müller PJ</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Strzalkowski+T%22">Strzalkowski T</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Trefny+MP%22">Trefny MP</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Endres+S%22">Endres S</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Jenkins+RW%22">Jenkins RW</searchLink>; Mass General Cancer Center, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Böttcher+JP%22">Böttcher JP</searchLink>; Institute of Molecular Immunology, TUM University Hospital, School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.; M3 Research Center, University Hospital Tübingen, University of Tübingen, Tübingen, Germany.; Department of Experimental Immunology, Institute of Immunology, University of Tübingen, Tübingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kobold+S%22">Kobold S</searchLink>; Institute of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the LMU University Hospital, LMU, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München-German Research Center for Environmental Health Neuherberg, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.; German Center for Lung Research (DZL), Partner Site Munich, Munich, Germany. Sebastian.kobold@med.uni-muenchen.de.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101696896%22">Nature biomedical engineering</searchLink> [Nat Biomed Eng] 2026 Apr; Vol. 10 (4), pp. 697-710. <i>Date of Electronic Publication: </i>2026 Feb 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101696896 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2157-846X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222157846X%22">2157846X </searchLink><i>NLM ISO Abbreviation: </i>Nat Biomed Eng <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41673138
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41551-025-01610-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 697
    Titles:
      – TitleFull: Ablation of prostaglandin E2 signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dörr J
      – PersonEntity:
          Name:
            NameFull: Gregor L
      – PersonEntity:
          Name:
            NameFull: Lacher SB
      – PersonEntity:
          Name:
            NameFull: Oner A
      – PersonEntity:
          Name:
            NameFull: Sun Y
      – PersonEntity:
          Name:
            NameFull: Piseddu I
      – PersonEntity:
          Name:
            NameFull: Fertig L
      – PersonEntity:
          Name:
            NameFull: Spajic S
      – PersonEntity:
          Name:
            NameFull: Lesch S
      – PersonEntity:
          Name:
            NameFull: Michaelides S
      – PersonEntity:
          Name:
            NameFull: Seifert M
      – PersonEntity:
          Name:
            NameFull: Gottschlich A
      – PersonEntity:
          Name:
            NameFull: Samson N
      – PersonEntity:
          Name:
            NameFull: Majed L
      – PersonEntity:
          Name:
            NameFull: Briukhovetska D
      – PersonEntity:
          Name:
            NameFull: Simnica D
      – PersonEntity:
          Name:
            NameFull: Hartmann V
      – PersonEntity:
          Name:
            NameFull: Gabriel K
      – PersonEntity:
          Name:
            NameFull: Cohen S
      – PersonEntity:
          Name:
            NameFull: Boland GM
      – PersonEntity:
          Name:
            NameFull: Andreu-Sanz D
      – PersonEntity:
          Name:
            NameFull: Carlini E
      – PersonEntity:
          Name:
            NameFull: Stock S
      – PersonEntity:
          Name:
            NameFull: Holtermann A
      – PersonEntity:
          Name:
            NameFull: Müller PJ
      – PersonEntity:
          Name:
            NameFull: Strzalkowski T
      – PersonEntity:
          Name:
            NameFull: Trefny MP
      – PersonEntity:
          Name:
            NameFull: Endres S
      – PersonEntity:
          Name:
            NameFull: Jenkins RW
      – PersonEntity:
          Name:
            NameFull: Böttcher JP
      – PersonEntity:
          Name:
            NameFull: Kobold S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2026 Apr
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2157-846X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Nature biomedical engineering
              Type: main
ResultId 1